Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
Study on the Safety and Effectiveness of ABBV-668 for Adults with Moderate to Severe Ulcerative Colitis
BelgiumStudy of Obexelimab for Patients with Warm Autoimmune Hemolytic Anemia
ItalyStudy on Linsitinib for Patients with Active, Moderate to Severe Thyroid Eye Disease
ItalyStudy on the Safety of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells for Treating Inflammatory Bowel Strictures in Crohn's Disease Patients
SpainStudy on Long-Acting Cabotegravir and Rilpivirine for HIV Patients in Spain: Evaluating Out-of-Hospital Treatment Options
SpainStudy on Volixibat for Treating Itching in Patients with Primary Biliary Cholangitis
BelgiumStudy on Ustekinumab for Children with Moderate to Severe Ulcerative Colitis
BelgiumStudy on Ustekinumab for Children with Moderate to Severe Crohn's Disease
BelgiumStudy on the Long-Term Safety and Effectiveness of Amlitelimab for Adults with Moderate to Severe Atopic Dermatitis
CzechiaStudy on Long-Term Safety of Ligelizumab for Patients with Food Allergies
FranceStudy on the Effectiveness and Safety of Sublingual Immunotherapy with Betula Pendula Pollen Extract for Patients with Birch Pollen Allergy
GermanyStudy on the Safety and Effectiveness of Deucravacitinib for Patients with Active Discoid and/or Subacute Cutaneous Lupus Erythematosus
FranceThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
